Pazopanib dosage adjustment and detailed explanation of individualized treatment plans

Pazopanib, also known as pazopanib, is an oral multi-target tyrosine kinase inhibitor mainly used to treat advanced renal cell carcinoma (RCC) and certain soft tissue sarcomas. The standard recommended dose is 800 mg once a day, taken orally on an empty stomach (avoid taking it with high-fat meals to avoid affecting drug absorption). However, in clinical practice, not all patients can tolerate this standard dose, so individualized adjustment of the dosage is crucial.

In terms of dose adjustment, the dose of pazopanib often needs to be reduced due to adverse reactions. Common side effects include high blood pressure, diarrhea, elevated liver enzymes, fatigue, hair discoloration, etc. If the patient experiences grade 2 or above toxic reactions, it is recommended that the doctor reduce the dose to 600 mg or 400 mg per day after evaluating the condition. For patients with severe liver function abnormalities, special caution should be taken. It is generally recommended that the dose be reduced to 200 mg daily, or even the medication may be suspended depending on the condition.

Individualized treatment requires comprehensive consideration of the patient's weight, age, liver and kidney function status, and comorbid diseases. For example, when elderly patients or those with multiple underlying diseases use pazopanib, they should start with a low dose and closely monitor blood pressure, liver function, electrocardiogram and other indicators. During treatment, it is recommended to regularly review blood routine, liver and kidney function, and blood pressure to ensure medication safety. Some patients may need to adjust their dose due to excessive drug exposure due to differences in CYP3A4 metabolic activity.
In general, although pazopanib has definite efficacy in multiple cancer types, its side effects are somewhat unpredictable, so dose management needs to be based on patient tolerance. Clinically, it is recommended to set a personalized treatment plan based on individual patient differences to ensure the efficacy while minimizing side effects, thereby improving treatment compliance and quality of life, and achieving long-term benefits.
Reference: https://www.votrient.com/